CEBEDEX Trademark

Trademark Overview


On Thursday, June 13, 2013, a trademark application was filed for CEBEDEX with the United States Patent and Trademark Office. The USPTO has given the CEBEDEX trademark a serial number of 85959221. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Monday, September 21, 2015. This trademark is owned by GW Pharma Limited. The CEBEDEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome; herbs for medicinal purposes; medicina...
cebedex

General Information


Serial Number85959221
Word MarkCEBEDEX
Filing DateThursday, June 13, 2013
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateMonday, September 21, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 13, 2014

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, bladder disfunction, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse; herb teas for medicinal purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, September 21, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Party NameGW Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalisbury SP4OJR
GB

Trademark Events


Event DateEvent Description
Monday, September 21, 2015ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Monday, September 21, 2015ABANDONMENT - AFTER INTER PARTES DECISION
Monday, September 21, 2015OPPOSITION TERMINATED NO. 999999
Monday, September 21, 2015OPPOSITION SUSTAINED NO. 999999
Thursday, November 13, 2014CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, November 12, 2014ASSIGNED TO PETITION STAFF
Monday, November 10, 2014OPPOSITION INSTITUTED NO. 999999
Thursday, November 6, 2014TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, June 11, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 13, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 13, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 23, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 10, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 7, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 31, 2014ASSIGNED TO LIE
Tuesday, March 18, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 19, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2013NON-FINAL ACTION E-MAILED
Thursday, September 19, 2013NON-FINAL ACTION WRITTEN
Sunday, September 15, 2013ASSIGNED TO EXAMINER
Friday, June 21, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 17, 2013NEW APPLICATION ENTERED IN TRAM